EMILY MCGOWAN: Open Payments
NPI 1104172287 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $75 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $68 |
| Novo Nordisk Inc | 3 | $57 |
| PFIZER INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: ELIQUIS, TRELEGY ELLIPTA, Ozempic, EVENITY, CAPVAXIVE, Rybelsus, MOUNJARO, REPATHA.
Industry payments across NY — which companies pay providers there.
